Skip to main content
Clinical Trials/NCT04619771
NCT04619771
Unknown
Not Applicable

M-Health Administered Sleep Treatment to Enhance Recovery in Bariatric Populations (MASTER)

Stony Brook University1 site in 1 country20 target enrollmentJanuary 1, 2021

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Insomnia
Sponsor
Stony Brook University
Enrollment
20
Locations
1
Primary Endpoint
ActiGraph Use
Last Updated
5 years ago

Overview

Brief Summary

This study is a longitudinal clinical trial designed to assess the feasibility of sleep intervention (Cognitive Behavioral Therapy for Insomnia (CBT-I)) in individuals with insomnia following bariatric surgery.

Registry
clinicaltrials.gov
Start Date
January 1, 2021
End Date
February 2022
Last Updated
5 years ago
Study Type
Interventional
Study Design
Single Group
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Genna Popovich Hymowitz

Clinical Assistant Professor

Stony Brook University

Eligibility Criteria

Inclusion Criteria

  • Age 18-64
  • Fluency with English
  • Willingness to maintain an active telehealth platform account
  • Daily access to wireless internet connection or sufficient cell phone service for telemedicine
  • Undergone bariatric surgery (Roux-en-Y or vertical sleeve gastrectomy) within past 1-3 years
  • Must have experienced \<50% excess weight loss following surgery Clinically significant insomnia (i.e., ISI score \>11)

Exclusion Criteria

  • Patient underwent revision of initial weight loss procedure
  • PHQ-9 Depression score \> 15
  • GAD-7 Anxiety score \> 15
  • Current alcohol or substance abuse
  • Current narcotic use
  • Unstable major psychiatric condition
  • Restless leg syndrome
  • Sleep apnea with non-adherence to CPAP intervention (i.e., use of CPAP \<4 nights/week)
  • Other problems at investigator discretion
  • Vulnerable populations (e.g., adults unable to consent, ages \<18, pregnant women, and prisoners).

Outcomes

Primary Outcomes

ActiGraph Use

Time Frame: Follow Up (week 15)

The average percentage of days spent wearing the medical-grade Fitbit-like-device that collects sleep and physical activity data to help assess feasibility.

Recruitment Rate

Time Frame: Follow Up (week 15)

Number of participants screened into the study per month will help measure feasibility.

Completion of Study Measures

Time Frame: Follow Up (week 15)

The average percentage of study measures (self-report questionnaires, daily diaries and CBT-I sessions) that are completed across participants will help determine feasibility.

Actigraph Compliance

Time Frame: Follow Up (week 15)

The average percentage of hours of wear per day of the medical-grade Fitbit-like-device that collects sleep and physical activity data to help assess feasibility.

Secondary Outcomes

  • Treatment Acceptability(Follow Up (week 15))
  • Change in sleep onset latency(Follow-up (week 15))
  • Change in wake after sleep onset (WASO)(Follow-up (week 15))
  • Change in total sleep time (TST)(Follow-up (week 15))
  • Change in Insomnia Severity(Visit 1 (Week 3), Visit 5 (Week 11), Follow up (Week 15))
  • Change in BMI(Baseline (week 1), Follow-up (week 15))
  • % Total Weight Loss(Baseline (week 1), Follow-up (week 15))
  • Change in sleep efficiency(Follow-up (week 15))
  • % Excess Weight Loss(Baseline (week 1), Follow-up (week 15))

Study Sites (1)

Loading locations...

Similar Trials